The antineoplastic bryostatins affect human basophils and mast cells differently.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Blood

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V85.5.1272.BLOODJOURNAL8551272PMID 7532037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A bryostatin-sensitive protein kinase C required for nerve growth factor activity.

  1994cited by this paper
• New concepts about the mast cell

  1994cited by this paper
• Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils.

  1994cited by this paper
• The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with recombinant murine granulocyte-macrophage colony-stimulating factor, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation.

  1994cited by this paper
• New concepts about the mast cell.

  1993cited by this paper
• Bryostatin 1: will the oceans provide a cancer cure?

  1993cited by this paper
• Inositol trisphosphate and calcium signalling

  1993cited by this paper
• Heterogeneity of human FcεRI-bearing cells

  1993cited by this paper
• Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.

  1993cited by this paper
• Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor α Induction In Vivo

  1993cited by this paper
• Heterogeneity of human Fc epsilon RI-bearing cells.

  1993cited by this paper
• Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.

  1993cited by this paper
• Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

  1992cited by this paper
• Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor.

  1992cited by this paper
• Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.

  1992cited by this paper
• The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.

  1992cited by this paper
• Interleukin 4 is localized to and released by human mast cells

  1992cited by this paper
• Binding of [3H]bryostatin 4 to protein kinase C.

  1992cited by this paper
• Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.

  1992cited by this paper
• Characterization of the anti-inflammatory effect of FK-506 on human mast cells.

  1991cited by this paper
• Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition.

  1991cited by this paper
• Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.

  1991cited by this paper
• FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.

  1991cited by this paper
• Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation

  1990cited by this paper
• Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.

  1990cited by this paper
• The human basophil.

  1990cited by this paper
• Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.

  1990cited by this paper
• Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.

  1990cited by this paper
• Mast cells as a source of multifunctional cytokines.

  1990cited by this paper
• Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.

  1990cited by this paper
• Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin.

  1990cited by this paper
• Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.

  1989cited by this paper
• Differential Release of Mediators From Human Basophils: Differences in Arachidonic Acid Metabolism Following Activation by Unrelated Stimuli

  1989cited by this paper
• Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain.

  1988cited by this paper
• Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture.

  1988cited by this paper
• Regulation of hematopoiesis-IV: The role of interleukin-3 and bryostatin 1 in the growth of erythropoietic progenitors from normal and anemic W/Wv mice.

  1988cited by this paper
• Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.

  1988cited by this paper
• Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

  1988cited by this paper
• Activation of human T lymphocytes by bryostatin.

  1988cited by this paper
• Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).

  1987cited by this paper
• Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.

  1987cited by this paper
• Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.

  1987cited by this paper
• Co-induction of lymphokine synthesis by the antineoplastic bryostatins.

  1987cited by this paper
• Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

  1986cited by this paper
• Studies and perspectives of protein kinase C.

  1986cited by this paper
• Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.

  1986cited by this paper
• Metabolic comparison between basophils and other leukocytes from human blood.

  1986cited by this paper
• Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.

  1985cited by this paper
• Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• Identification of a calcium- and phospholipid- dependent phorbol ester binding activity in the soluble fraction of mouse tissues.

  1983cited by this paper
• Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

  1983cited by this paper
• Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli.

  1982cited by this paper
• Mast cells in hemangiomas and vascular malformations.

  1982cited by this paper
• Human lung mast cells: purification and characterization.

  1982cited by this paper
• Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response.

  1981cited by this paper
• Melanoma. An ultrastructural study of the host inflammatory and vascular responses.

  1980cited by this paper
• Tumor-basophil interactions in vitro--a scanning and transmission electron microscopic study.

  1979cited by this paper
• Basophil counting with a new staining method using alcian blue.

  1975cited by this paper
• An automated continuous-flow system for the extraction and fluorometric analysis of histamine.

  1974cited by this paper

• Immunopharmacological modulation of mast cells.

  2014cites this paper
• Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.

  2013cites this paper
• Methode de traitement de la maladie d'alzheimer et d'amelioration cognitive

  2005cites this paper
• Pharmacological modulation of human mast cells and basophils

  2002cites this paper
• CHAPTER 12 – BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS

  2002cites this paper
• Envelope gp120 of HIV-1 binds to and activates human basophils

  2001cites this paper
• Expression of the Chemokine Receptor CCR3 on Human Mast Cells

  2001cites this paper
• HIV-1 gp120 Induces IL-4 and IL-13 Release from Human FcεRI+ Cells Through Interaction with the VH3 Region of IgE1

  2000cites this paper
• Role of basophils in airways inflammation

  2000cites this paper
• Histamine plasma levels and elimination diet in chronic idiopathic urticaria

  2000cites this paper
• The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils

  2000cites this paper
• Mechanisms of IgE elevation in HIV-1 infection.

  2000cites this paper
• 3 Region of IgE H Interaction with the V Cells Through + RI e from Human Fc HIV-1 gp120 Induces IL-4 and IL-13 Release

  1999cites this paper
• Stem cell factor is localized in, released from, and cleaved by human mast cells.

  1999cites this paper
• Endogenous Superallergen Protein Fv Interacts with the VH3 Region of IgE to Induce Cytokine Secretion from Human Basophils

  1999cites this paper
• Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

  1999cites this paper
• Immunopharmacology of human mast cells and basophils

  1998cites this paper
• Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE.

  1998cites this paper
• The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: synergy with interleukin-2 and modulation of interleukin-2Rgamma chain expression.

  1997cites this paper
• Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cells

  1997cites this paper
• Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.

  1997cites this paper
• Granulocyte colony‐stimulating factor‐induced activation of protein kinase‐C in myeloid cells

  1997cites this paper
• Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.

  1997cites this paper
• Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.

  1997cites this paper
• Heterogeneous effects of protamine on human mast cells and basophils.

  1997cites this paper
• Multifunctional modulators of drug resistance.

  1996cites this paper
• Eosinophil granule proteins activate human heart mast cells.

  1996cites this paper
• Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependency.

  1996cites this paper
• Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism.

  1996cites this paper
• Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue

  1996cites this paper
• Progress in the discovery of biosynthetic anticancer drugs.

  1996cites this paper
• Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.

  1996cites this paper
• Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.

  1996cites this paper
• Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.

  1996cites this paper